disruptions is the sole category represented across all 1 tracked stories. prokerala.com is most often covered alongside Active Pharmaceutical Ingredients, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.2 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about prokerala.com
disruptions is the sole category represented across all 1 tracked stories. prokerala.com is most often covered alongside Active Pharmaceutical Ingredients, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.2 in the same window. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. We currently track 1 Supply Chain story that mention prokerala.com, all published on September 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Supply Chain stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering prokerala.com. Shared-story counts are live from our verified record — not editorial picks.
A new report urges the EU to copy the UK's playbook for decoupling critical supply chains from China by shifting electronics, solar components, pharmaceuticals, and rare earths sourcing toward India. Procurement and manufacturing leaders should note the call for a phased, sector-by-sector transition rather than an abrupt switch.